I stumbled upon some interesting information that is available on the web - the 2006 AstraZeneca business review. It covers the drugs they have in their pipeline and the findings of any studies so far. Much of it is too scientific for me to understand, but there is definitely some interesting information. It really seems like there is confidence in the MEK inhibitor as the future of cancer treatment.
You can check out the document here - 2006 Business Review.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment